Dr. Ewa Marta Szemraj, MD

Dr. Szemraj practices at Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium.

Dr. Szemraj's NPI, 1861406779, was assigned on July 28, 2006. Dr. Szemraj holds New York license 188990.

Dr. Szemraj's primary practice is Alaska Native Medical Center, at 4315 Diplomacy Dr, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 563-2662.

Dr. Szemraj's primary practice is Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium. Dr. Szemraj is also affiliated with NYC Health + Hospitals/Elmhurst. The medical group on file is Alaska Native Medical Center. Dmand AI also links Dr. Szemraj to 2 more group practices and clinics and 2 medical groups, each named with a free account. Dr. Szemraj's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Szemraj practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Szemraj's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Szemraj is licensed in New York.

CMS data shows 428 Medicare services from Dr. Szemraj across 2 procedure codes in 2024, all of them office visits, for 158 Medicare patients. Medicare paid $35,648 for them.

CMS counts 158 Medicare patients who saw Dr. Szemraj in 2024. The largest group is 65 to 74, with 76 patients. 65% of them have high blood pressure, and 61% have cancer. 53% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Szemraj's median patient age at 71, with 57% women.

In 2024, Dr. Szemraj wrote 353 Medicare Part D claims for 58 patients. 71% of them were for generic drugs. CMS names the drug for 230 of them, across 11 drugs with 11 or more claims each, at $514,807 in total drug cost. In 2023, CMS named 200 claims across 12 drugs.

Dr. Szemraj accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Szemraj as offering telehealth.

CMS Open Payments shows 24 general payments to Dr. Szemraj from 15 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 90% of the total. Bristol-Myers Squibb Company paid the most, $311.